How ATP Works

Expand All | Collapse All

ABOUT ATP

ATP in the 21^st Century

Contact Information

Doing Business With ATP

FUNDED PROJECTS

Completed Status Reports

Gems and Success Stories

Project Briefs

IMPACTS OF ATP FUNDING

Acceleration and High Technology Analyses

Collaboration Analyses

Commercialization Analyses

Funding Gap and Other Policy Research Analyses

Performance Assessment and Metrics

Social, Economic and Other Benefits

Spillover and Diffusion Analyses

Technology Area Analyses

PARTNERSHIPS

Universities and Non-profit

STATISTICS

ATP Awards by State

ATP Awards by Year

Characteristics of ATP Awards

Characteristics of Technology Areas

Cumulative Award Statistics

Technology Areas by Year

Advanced Technology Program
NIST
100 Bureau Drive, STOP 4701
Gaithersburg, MD 20899-4701

ATP web site comments:
web master-atp@nist.gov

Technical ATP inquiries:
InfoCoord.ATP@nist.gov

Last updated: 07/31/2008

What's New in ATP

The President signed the America COMPETES Act (H.R. 2272) on August 9, 2007.

This statute abolishes the Advanced Technology Program (ATP), but allows for continued support for previously awarded projects and the 56 new FY 2007 awards.

Separately the statute created the Technology Innovation Program (TIP). For more information about this program, see: http://www.nist.gov/tip/

SUCCESS STORIES — Visit our new gallery of gems and success stories ... which highlight the important links between ATP and industry cost-shared funding for high-risk research and development and their economic benefits to our Nation. To learn more about these and other successes ...

TOP STORIES
• Virent Energy Systems, Inc., was selected as a Red Herring North America 100 winner. This award distinguishes North America's top technology startup companies for 2008.
• Dr. Michael Long (CEO, Velcura Therapeutics) was named the Third Annual Grant Thornton Leader and Innovator of the Year at Lawrence Technological University." The of complete press release can be found at http://www.velcura.com/news/2008/may/09/2008-leader-and-innovator-of-the-year.
• Osiris Therapeutics, Inc., announces positive phase I clinical trial results for PROVACEL, an adult mesenchymal stem cell therapy developed using the ATP funded technology, in patients with heart disease.
• Tepha Receives FDA Clearance for First Medical Device Derived from New Class of Biopolymers ... The development of the TephaFLEX Absorbable Suture was supported by grants from the National Institutes of Health (NIH), and the U.S. Department of Commerce's National Institute of Standards and Technology Advanced Technology Program (NIST ATP).
• Zimmer Holdings and ISTO Technologies Announce Start of Neocartilage Clinical Trial ... ISTO Technologies begins clinical trial for Neocartilage, a living tissue-engineered graft for the restoration of cartilage defects, reestablishment of joint function and relief of pain in the knee.